Abstract
Embarking on the dynamic landscape of oncology, this chapter navigates the interface between emerging concepts and transformative advancements in cancer research. It delves into the intricate symbiosis of viruses and cancers, spotlighting the diverse roles of small DNA tumor viruses, RNA oncoviruses, and their diagnostic potential. Additionally, the discourse examines the evolving vistas of cancer genetics, accentuating the significance of oncogenes and their interactions with energy metabolism pathways. By traversing these complex dimensions, the chapter contributes to an enriched understanding of contemporary oncobiological paradigms.
This is a preview of subscription content, log in via an institution to check access.
References
American cancer society. (2022). Viruses that can lead to cancer. Accessed at https://www.cancer.org/cancer/risk-prevention/infections/infections-that-can-lead-to-cancer/viruses.htm
Ansó E, Weinberg SE, Diebold LP, Thompson BJ, Malinge S, Schumacker PT, Liu X, Zhang Y, Shao Z, Steadman M, Marsh KM, Xu J, Crispino JD, Chandel NS (2017) The mitochondrial respiratory chain is essential for haematopoietic stem cell function. Nat Cell Biol 19(6):614–625. https://doi.org/10.1038/NCB3529
Aqeilan RI, Calin GA, Croce CM (2010) miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17:215–220
Bensaad K, Tsuruta A, Selak MA, Vidal MNC, Nakano K, Bartrons R, Gottlieb E, Vousden KH (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126(1):107–120. https://doi.org/10.1016/J.CELL.2006.05.036
Bilzer M, Roggel F, Gerbes AL (2006) Role of Kupffer cells in host defense and liver disease. Liver Int 26(10):1175–1186. https://doi.org/10.1111/J.1478-3231.2006.01342.X
Bock CT, Toan NL, Koeberlein B, Song LH, Chin R, Zentgraf H, Kandolf R, Torresi J (2008) Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma. Intervirology 51(6):432–443. https://doi.org/10.1159/000209672
Cardone RA, Casavola V, Reshkin SJ (2005) The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat Rev Cancer 5(10):786–795. https://doi.org/10.1038/NRC1713
Cheng C, Geng F, Cheng X, Guo D (2018) Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond) 38(1):27. https://doi.org/10.1186/S40880-018-0301-4
Chin R, Earnest-Silveira L, Koeberlein B, Franz S, Zentgraf H, Bowden S, Bock CT, Torresi J (2008) Failure of lamivudine to reverse hepatitis B virus-associated changes in ERK, Akt and cell cycle regulatory proteins. Antivir Ther 13(2):221–230. https://doi.org/10.1177/135965350801300201
Chung W, Kim M, de la Monte S, Longato L, Carlson R, Slagle BL, Dong X, Wands JR (2016) Activation of signal transduction pathways during hepatic oncogenesis. Cancer Lett 370(1):1–9. https://doi.org/10.1016/J.CANLET.2015.09.016
Cruz-Gregorio A, MartÃnez-RamÃrez I, Pedraza-Chaverri J, Lizano M (2019) Reprogramming of energy metabolism in response to radiotherapy in head and neck squamous cell carcinoma. Cancers 11(2):182. https://doi.org/10.3390/CANCERS11020182
Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24(2):68–72. https://doi.org/10.1016/S0968-0004(98)01344-9
De Berardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2(5):e1600200. https://doi.org/10.1126/SCIADV.1600200
Del Bufalo D, Biroccio A, Soddu S, Laudonio N, D’Angelo C, Sacchi A, Zupi G (1996) Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene. J Clin Invest 98(5):1165–1173. https://doi.org/10.1172/JCI118900
Dong Z, Wei H, Sun R, Tian Z (2007) The roles of innate immune cells in liver injury and regeneration. Cell Mol Immunol 4(4):241–252. https://europepmc.org/article/med/17764614
Fang M, Shen Z, Huang S, Zhao L, Chen S, Mak TW, Wang X (2010) The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell 143(5):711–724. https://doi.org/10.1016/J.CELL.2010.10.010
Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9(6):425–434. https://doi.org/10.1016/J.CCR.2006.04.023
Felsani A, Mileo AM, Paggi MG (2006) Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene 25(38):5277–5285. https://doi.org/10.1038/SJ.ONC.1209621
Franchini G, Fukumoto R, Fullen JR (2003) T-cell control by human T-cell leukemia/lymphoma virus type 1. Int J Hematol 78(4):280–296. https://doi.org/10.1007/BF02983552
Fung J, Lai C-L, But D, Wong D, Cheung T-K, Yuen M-F (2008) Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management. Am J Gastroenterol 103(6):1421. https://journals.lww.com/ajg/Fulltext/2008/06000/Prevalence_of_Fibrosis_and_Cirrhosis_in_Chronic.20.aspx
Garber K (2006) Energy deregulation: licensing tumors to grow. Science 312(5777):1158–1159. https://doi.org/10.1126/SCIENCE.312.5777.1158
Gatenby RA, Gillies RJ (2007) Glycolysis in cancer: a potential target for therapy. Int J Biochem Cell Biol 39(7–8):1358–1366. https://doi.org/10.1016/J.BIOCEL.2007.03.021
Gordan JD, Thompson CB, Simon MC (2007) HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 12(2):108–113. https://doi.org/10.1016/J.CCR.2007.07.006
Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481(7381):306–313. https://doi.org/10.1038/nature10762
Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M, Ohashi T, Fukui F, Hasegawa A, Masuda T, Takaue Y, Okamura J, Kannagi M (2004) Graft-versus-tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 64(1):391–399. https://doi.org/10.1158/0008-5472.CAN-03-1452
Harguindey S, Orive G, Pedraz JL, Paradiso A, Reshkin SJ (2005) The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin – one single nature. Biochim Biophys Acta 1756(1):1–24. https://doi.org/10.1016/J.BBCAN.2005.06.004
Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson CB (2005) ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8(4):311–321. https://doi.org/10.1016/J.CCR.2005.09.008
Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W (2004) Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25(10):2023–2032. https://doi.org/10.1093/CARCIN/BGH207
Hulleman E, Kazemier KM, Holleman A, VanderWeele DJ, Rudin CM, Broekhuis MJC, Evans WE, Pieters R, Boer MLD (2009) Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood 113(9):2014–2021. https://doi.org/10.1182/BLOOD-2008-05-157842
Iorio MV, Croce CM (2012) microRNA involvement in human cancer. Carcinogenesis 33(6):1126–1133. https://doi.org/10.1093/carcin/bgs140
Karin M (2008) The IkappaB kinase – a bridge between inflammation and cancer. Cell Res 18(3):334–342. https://doi.org/10.1038/CR.2008.30
Karin M, Greten FR (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749–759. https://doi.org/10.1038/nri1703
Khan S, Mahmood MS, Rahman SU, Zafar H, Habibullah S, Khan Z, Ahmad A (2018) CRISPR/Cas9: the Jedi against the dark empire of diseases. J Biomed Sci 25(1):29. https://doi.org/10.1186/S12929-018-0425-5
Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 11(5):325–337. https://doi.org/10.1038/nrc3038
Kusumoto S, Tanaka Y, Mizokami M, Ueda R (2009) Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J Hematol 90(1):13–23. https://doi.org/10.1007/S12185-009-0359-5/FIGURES/5
Li YC, Fung KP, Kwok TT, Lee CY, Suen YK, Kong SK (2002) Mitochondrial targeting drug lonidamine triggered apoptosis in doxorubicin-resistant HepG2 cells. Life Sci 71(23):2729–2740. https://doi.org/10.1016/S0024-3205(02)02103-3
Li JJ, Wang H, Tino JA, Robl JA, Herpin TF, Lawrence RM, Biller S, Jamil H, Ponticiello R, Chen L, Chu C, Flynn N, Cheng D, Zhao R, Chen B, Schnur D, Obermeier MT, Sasseville V, Padmanabha R … Harrity T (2007) 2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors. Bioorg Med Chem Lett 17(11):3208–3211. https://doi.org/10.1016/J.BMCL.2007.03.017
Liao JB (2006) Viruses and human cancer. Yale J Biol Med 79:115–122
Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41(3):211–218. https://doi.org/10.1016/J.TIBS.2015.12.001
Linehan WM, Schmidt LS, Crooks DR, Wei D, Srinivasan R, Lang M, Ricketts CJ (2019) The metabolic basis of kidney cancer. Cancer Discov 9(8):1006–1021. https://doi.org/10.1158/2159-8290.CD-18-1354
Liu ZL, Wang H, Liu J, Wang ZX (2013) MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem 372(1–2):35–45. https://doi.org/10.1007/s11010-012-1443-3
Ma EH, Verway MJ, Johnson RM, Roy DG, Steadman M, Hayes S, Williams KS, Sheldon RD, Samborska B, Kosinski PA, Kim H, Griss T, Faubert B, Condotta SA, Krawczyk CM, DeBerardinis RJ, Stewart KM, Richer MJ, Chubukov V … Jones RG (2019) Metabolic profiling using stable isotope tracing reveals distinct patterns of glucose utilization by physiologically activated CD8+ T cells. Immunity 51(5):856–870.e5. https://doi.org/10.1016/J.IMMUNI.2019.09.003
Mahboobi N, Tabatabaei SV, Blum HE, Alavian SM (2012) Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature. Transpl Infect Dis 14(5):445–451. https://doi.org/10.1111/J.1399-3062.2012.00782.X
Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129(7):1261–1274. https://doi.org/10.1016/J.CELL.2007.06.009
Mantovani F, Banks L (2001) The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20(54):7874–7887. https://doi.org/10.1038/SJ.ONC.1204869
Marshall S, Bacote V, Traxinger RR (1991) Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266(8):4706–4712
Martin GS, Bernard GR (2001) Acute respiratory distress syndrome: innovative therapies. Semin Respir Crit Care Med 22(3):293–306
Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM (2006) p53 regulates mitochondrial respiration. Science 312(5780):1650–1653. https://doi.org/10.1126/SCIENCE.1126863
Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, Fernandez AF, Davalos V, Villanueva A, Montoya G, Yamamoto H, Schwartz S Jr, Esteller M (2010) A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18(4):303–315. https://doi.org/10.1016/j.ccr.2010.09.007
Mollanoori H, Shahraki H, Rahmati Y, Teimourian S (2018) CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment. Hum Immunol 79(12):876–882. https://doi.org/10.1016/j.humimm.2018.09.007
Pelicano H, Martin DS, Xu RH, Huang P (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25(34):4633–4646. https://doi.org/10.1038/SJ.ONC.1209597
Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45(4):529–538. https://doi.org/10.1016/J.JHEP.2006.05.013
Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M … Zoulim F (2008) Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49(4):652–657. https://doi.org/10.1016/J.JHEP.2008.07.014
Ramanathan A, Wang C, Schreiber SL (2005) Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci U S A 102(17):5992–5997. https://doi.org/10.1073/PNAS.0502267102
Ravagnan L, Marzo I, Costantini P, Susin SA, Zamzami N, Petit PX, Hirsch F, Goulbern M, Poupon MF, Miccoli L, Xie Z, Reed JC, Kroemer G (1999) Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene 18(16):2537–2546. https://doi.org/10.1038/SJ.ONC.1202625
Reshkin SJ, Bellizzi A, Caldeira S, Albarani V, Malanchi I, Poignee M, Alunni-Fabbroni M, Casavola V, Tommasino M (2000) Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J 14(14):2185–2197. https://doi.org/10.1096/FJ.00-0029COM
Ringehan M, McKeating JA, Protzer U (2017) Viral hepatitis and liver cancer. Philos Trans R Soc Lond Ser B Biol Sci 372(1732):20160274. https://doi.org/10.1098/RSTB.2016.0274
Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67(20):9762–9770. https://doi.org/10.1158/0008-5472.CAN-07-2462
Scheffner M, Huibregtse JM, Howley PM (1994) Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc Natl Acad Sci U S A 91(19):8797–8801. https://doi.org/10.1073/pnas.91.19.8797
Schiller JT, Lowy DR (2021) An introduction to virus infections and human cancer. Recent Results Cancer Res 217:1–11. https://doi.org/10.1007/978-3-030-57362-1_1
Schuijers J, Manteiga JC, Weintraub AS, Day DS, Zamudio AV, Hnisz D, Lee TI, Young RA (2018) Transcriptional dysregulation of MYC reveals common enhancer-docking mechanism. Cell Rep 23(2):349–360. https://doi.org/10.1016/J.CELREP.2018.03.056
Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA, Wang CR, Schumacker PT, Licht JD, Perlman H, Bryce PJ, Chandel NS (2013) Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38(2):225–236. https://doi.org/10.1016/J.IMMUNI.2012.10.020
Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, Dang CV (1997) c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A 94(13):6658–6663. https://doi.org/10.1073/PNAS.94.13.6658
Simonnet H, Alazard N, Pfeiffer K, Gallou C, Béroud C, Demont J, Bouvier R, Schägger H, Godinot C (2002) Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 23(5):759–768. https://doi.org/10.1093/CARCIN/23.5.759
Sun G, Yan J, Noltner K, Feng J, Li H, Sarkis DA, Sommer SS, Rossi JJ (2009) SNPs in human miRNA genes affect biogenesis and function. RNA 15(9):1640–1651. https://doi.org/10.1261/rna.1560209
Suzuki T, Kitao S, Matsushime H, Yoshida M (1996) HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J 15(7):1607. https://doi.org/10.1002/j.1460-2075.1996.tb00505.x
Svoronos AA, Engelman DM, Slack FJ (2016) OncomiR or tumor suppressor? The duplicity of MicroRNAs in cancer. Cancer Res 76:3666–3670
Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, Liu Z (2010) MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 285(11):7986–7994. https://doi.org/10.1074/jbc.M109.062877
Valsamakis A (2007) Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev 20(3):426–439. https://doi.org/10.1128/CMR.00009-07/ASSET/54584F84-5BB8-4F87-86F3-FB2AB4429664/ASSETS/GRAPHIC/ZCM0030722110001.JPEG
Van Dooren S, Salemi M, Vandamme AM (2001) Dating the origin of the African human T-cell lymphotropic virus type-i (HTLV-I) subtypes. Mol Biol Evol 18(4):661–671. https://doi.org/10.1093/OXFORDJOURNALS.MOLBEV.A003846
Vaupel P, Schmidberger H, Mayer A (2019) The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. International journal of radiation biology 95(7):912–919. https://doi.org/10.1080/09553002.2019.1589653
Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132(5):875–886
Villar VH, Merhi F, Djavaheri-Mergny M, Durán RV (2015) Glutaminolysis and autophagy in cancer. Autophagy 11(8):1198. https://doi.org/10.1080/15548627.2015.1053680
Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L (2019) Macrophages and metabolism in the tumor microenvironment. Cell Metab 30(1):36–50. https://doi.org/10.1016/J.CMET.2019.06.001
Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, Sano M, Ikeda S, Takatsuki K, Kozuru M, Araki K, Kawano F, Niimi M, Tobinai K, Hotta T, Shimoyama M (2001) A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113(2):375–382. https://doi.org/10.1046/J.1365-2141.2001.02737.X
Yang L, Venneti S, Nagrath D (2017) Glutaminolysis: a Hallmark of cancer metabolism. Annu Rev Biomed Eng 19:163–194. https://doi.org/10.1146/ANNUREV-BIOENG-071516-044546
Yoshida M (2003) Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 19:475–496. https://doi.org/10.1146/ANNUREV.IMMUNOL.19.1.475
Yuan Y, Li H, Pu W, Chen L, Guo D, Jiang H, He B, Qin S, Wang K, Li N, Feng J, Wen J, Cheng S, Zhang Y, Yang W, Ye D, Lu Z, Huang C, Mei J, Zhang HF, … Zhao SM (2022) Cancer metabolism and tumor microenvironment: fostering each other?. Science China. Life sciences 65(2):236–279. https://doi.org/10.1007/s11427-021-1999-2
Yuen MF, Wong DKH, Fung J, Ip P, But D, Hung I, Lau K, Yuen JCH, Lai CL (2008) HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 135(4):1192–1199. https://doi.org/10.1053/J.GASTRO.2008.07.008
Zhen S, Hua L, Liu YH, Sun XM, Jiang MM, Chen W, Zhao L, Li X (2017) Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer. Oncotarget 8(6):9634–9646. https://doi.org/10.18632/ONCOTARGET.14176
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2024 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Gosipatala, S.B. et al. (2024). Current Concepts and Advances in Oncobiology. In: Sobti, R.C., Ganguly, N.K., Kumar, R. (eds) Handbook of Oncobiology: From Basic to Clinical Sciences. Springer, Singapore. https://doi.org/10.1007/978-981-99-6263-1_80
Download citation
DOI: https://doi.org/10.1007/978-981-99-6263-1_80
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-6262-4
Online ISBN: 978-981-99-6263-1
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences